Eric Soller, Ph.D., is BlueRock’s VP of corporate development and strategy. Dr. Soller led the launch of BlueRock as an entrepreneur-in-residence at Versant Ventures, a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. Prior to joining Versant in 2016, Dr. Soller was a junior partner in McKinsey & Company’s New York office and a leader in the firm’s healthcare and corporate finance practices. He has advised leading biopharma companies on a range of strategic and operational issues across marketing, sales, R&D, and business and corporate development. He holds a B.S. in mechanical engineering with minors in applied biology and biomedical engineering from the Rose-Hulman Institute of Technology, and a Ph.D. in mechanical engineering with a biomedical focus from the Massachusetts Institute of Technology, where his scientific work centered on induced organ regeneration.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.